
Weight-Loss Drugs Bite Into Greggs' Bottom Line
Greggs acknowledges that the increasing popularity of weight loss drugs is impacting its sales, as consumers opt for smaller portions and healthier, protein-rich options. This shift in consumer behavior, coupled with a broader health trend, has contributed to the bakery chain's muted profit forecast for the coming year, prompting Greggs to adapt its menu with new product offerings. The company is actively targeting customers using GLP-1 drugs by introducing smaller portions and protein-rich products.























